| abstract |
Disclosed are a compound that inhibits the expression of a specific human gene, and a pharmaceutical composition containing the compound and a pharmaceutically acceptable carrier. SOLUTION: TP53BP2, LRDD, CYBA, ATF3, CASP2, NOX3, HRK, CIQBP, BNIP3, MAPK8, MAPK14, RAC1, GSK3B, P2RX7, TRPM2, PARG, CD38, STEAP4, BMP2, CX43, T Inhibitors of pro-apoptotic genes selected from the group consisting of RTN4R, ANXA2, RHOA, and DUOX1. The inhibitor is selected from the group consisting of siRNA, shRNA, aptamer, antisense molecule, miRNA, ribozyme, and antibody. Is preferred. [Selection figure] None |